Commonwealth Biotechnologies, Inc. to Present at the Wall Street Analyst Forum.RICHMOND, Va. -- Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CBTE), today announced that Dr. Robert B. Harris, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Dr. Richard J. Freer, Chair and COO, have been invited to present a corporate overview Wednesday, June 14 at 8:30 AM during the Biotechnology and Special Pharma session of the Wall Street Analyst's Forum's (WSAF WSAF Warwick Student Arts Festival (University of Warwick; UK) ) 17th Annual Analyst Conference, taking place at the Princeton Club in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The WSAF caters to buy side and sell side-analysts and portfolio managers. Dr. Harris' presentation will be webcast live from the Forum and interested parties may access the webcast from the link to be posted to CBI's webpage at www.cbi-biotech.com. The presentation slides will also be posted to the Company's webpage a few days after June 14th. About CBI Commonwealth Biotechnologies, Inc. is a solutions provider to the global biotechnology industry, academic institutions, government agencies, and pharmaceutical companies. It offers broad ranging expertise and a complete array of the most current analytical and synthetic chemistries and biophysical analysis technologies, many of which are not available from other commercial sources. CBI has crafted a stimulating, open environment where scientists collaborate among themselves and with our clients, take on interesting challenges and develop creative solutions. Through its FIL division, CBI offers comprehensive genetic identity testing, including paternity, forensic, and CODIS CODIS Combined DNA Index System (US FBI) CODIS Convicted Offender DNA Index System CODIS Component and Distributed Systems analyses. CBI is accredited accredited recognition by an appropriate authority that the performance of a particular institution has satisfied a prestated set of criteria. accredited herds cattle herds which have achieved a low level of reactors to, e.g. by the American Association of Blood Banks, CLIA CLIA Clinical Laboratory Improvement Amendments of 1988 Congressional legislation that promulgated quality assurance practices in clinical labs, and required them to measure performance at each step of the testing process from the beginning to the end-point of a , and the National Forensic Science Technology Council, and operates fully accredited BSL-3 laboratory. For more information, visit CBI on the web at www.cbi-biotech.com and visit FIL at www.fairfaxidlab.com. Any statements contained in this release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties as identified in the Company's filings with the Securities and Exchange Commission. Actual results, events or performance may differ materially. No statement herein should be considered an offer of any securities. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion